BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Thomas Shrader does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ALDXAldeyra The | Buy | $9.00 | Apr 2025 | −33.0% | Miss |
 ARCTArcturus Therapeutics Holdings Inc | Buy | $41.00 | Jan 2025 | −64.0% | Miss |
 ALECAlector Inc | Buy | $5.00 | Nov 2024 | −56.7% | Miss |
 PCVXVaxcyte Inc | Buy | $160.00 | Sep 2024 | −59.5% | Miss |
 ACIUAC Immune Ltd | Buy | $8.00 | May 2024 | −59.1% | Miss |
 PMNProMIS Neurosciences Inc. | Buy | $8.00 | Oct 2023 | −59.6% | Miss |
 DTILPrecision BioSciences Inc | Buy | $2.00 | Jul 2023 | −56.0% | Miss |
 BCABBioatla Inc | Buy | $13.00 | Mar 2023 | +20.0% | Miss |
 ABOSAcumen Pharmaceuticals Inc | Buy | $22.00 | Oct 2022 | −59.9% | Miss |
| ABOSAcumen Pharmaceuticals Inc | Buy | $15.00 | Jul 2022 | +61.1% | Miss |
 INMBINmune Bio Inc | Buy | $14.00 | May 2022 | +19.2% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.